Trial Profile
Phase II study of irinotecan, leucovorin, 5-fluorouracil (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 20 Oct 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 18 Apr 2011 Actual end date (March 2011) added as reported by ClinicalTrials.gov.
- 18 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.